Search Results - "Schatteman, Peter"

Refine Results
  1. 1

    Early Catheter Removal after Robot-assisted Radical Prostatectomy: Surgical Technique and Outcomes for the Aalst Technique (ECaRemA Study) by Gratzke, Christian, Dovey, Zach, Novara, Giacomo, Geurts, Nicolas, De Groote, Ruben, Schatteman, Peter, de Naeyer, Geert, Gandaglia, Giorgio, Mottrie, Alexandre

    Published in European urology (01-05-2016)
    “…Abstract Background Robot-assisted radical prostatectomy (RARP) is a widespread option for the treatment of patients with clinically localised prostate cancer…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Long‐term evaluation of survival, continence and potency (SCP) outcomes after robot‐assisted radical prostatectomy (RARP) by Ficarra, Vincenzo, Borghesi, Marco, Suardi, Nazareno, De Naeyer, Geert, Novara, Giacomo, Schatteman, Peter, De Groote, Ruben, Carpentier, Paul, Mottrie, Alexander

    Published in BJU international (01-08-2013)
    “…Objective To report combined oncological and functional outcome in a series of patients who underwent robot‐assisted radical prostatectomy (RARP) for…”
    Get full text
    Journal Article
  5. 5

    Robot-assisted Sacrocolpopexy for Pelvic Organ Prolapse: Surgical Technique and Outcomes at a Single High-volume Institution by Ploumidis, Achilles, Spinoit, Anne-Françoise, Naeyer, Geert De, Schatteman, Peter, Gan, Melanie, Ficarra, Vincenzo, Volpe, Alessandro, Mottrie, Alexandre

    Published in European urology (01-01-2014)
    “…Abstract Background Pelvic organ prolapse (POP) represents a common female pelvic floor disorder that has a serious impact on quality of life. Several types of…”
    Get full text
    Journal Article
  6. 6

    Validation of the preoperative aspects and dimensions used for an anatomical (PADUA) score in a robot-assisted partial nephrectomy series by Mottrie, Alexander, Schatteman, Peter, De Wil, Peter, De Troyer, Bart, Novara, Giacomo, Ficarra, Vincenzo

    Published in World journal of urology (01-08-2013)
    “…Objectives PADUA score is a standardized anatomical classification of renal tumors proposed with the aim to objectivize the decision-making process of any…”
    Get full text
    Journal Article
  7. 7

    Robot-Assisted Radical Cystectomy for Bladder Cancer in Octogenarians by De Groote, Ruben, Gandaglia, Giorgio, Geurts, Nicolas, Goossens, Marijn, Pauwels, Elisabeth, D'Hondt, Frederiek, Gratzke, Christian, Fossati, Nicola, De Naeyer, Geert, Schatteman, Peter, Carpentier, Paul, Novara, Giacomo, Mottrie, Alexandre

    Published in Journal of endourology (01-07-2016)
    “…To evaluate perioperative morbidity and mortality rate, a 3-year recurrence-free survival, and cancer-specific mortality rate in patients older than 80 years…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Metachronous metastasis of renal cell carcinoma to the urinary bladder: a case report by De Groote, Ruben, Larcher, Alessandro, Goossens, Marijn, Hendrik, De Raeve, Kris, Van Der Steen, De Coninck, Vincent, De Naeyer, Geert, Schatteman, Peter, D’Hondt, Frederiek, Mottrie, Alexandre

    Published in Therapeutic advances in urology (01-01-2018)
    “…We report a case of intravesical metastasis of a clear cell renal cell carcinoma. In renal cell carcinoma 16% of patients present with metastatic disease…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Impact of the Learning Curve on Perioperative Outcomes in Patients Who Underwent Robotic Partial Nephrectomy for Parenchymal Renal Tumours by Mottrie, Alexandre, De Naeyer, Geert, Schatteman, Peter, Carpentier, Paul, Sangalli, Mattia, Ficarra, Vincenzo

    Published in European urology (01-07-2010)
    “…Abstract Background Robot-assisted partial nephrectomy (RAPN) is an emerging, minimally invasive technique to treat patients with small renal masses. Objective…”
    Get full text
    Journal Article
  14. 14

    Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial by Smith, Matthew R, Scher, Howard I, Sandhu, Shahneen, Efstathiou, Eleni, Lara, Primo N, Yu, Evan Y, Chi, Kim N, Ståhl, Olof, Olmos, David, Danila, Daniel C, Espina, Byron M, Zhao, Xin, Urtishak, Karen A, Francis, Peter, Lopez-Gitlitz, Angela, Parnis, Francis, Horvath, Lisa G., Steer, Christopher, Marx, Gavin, Sandhu, Shahneen, Ferguson, Thomas, Luyten, Daisy, Lumen, Nicolaas, Dirix, Luc, Goeminne, Jean-Charles, Gil, Thierry, Vulsteke, Christof, Kussumoto, Celio, Franke, Fabio A., Martinelli de Oliveira, Fabricio Augusto, Pereira de Santana Gomes, Andrea Juliana, Preto, Daniel D'Almeida, Zucca, Luis Eduardo, Borges, Giuliano Santos, Murad, Andre M., Saad, Fred, Chi, Kim N., Fradet, Yves, Fleshner, Neil E., Emmenegger, Urban, Brasso, Klaus, Culine, Stephane, Thiery-Vuillemin, Antoine, Joly, Florence, Fléchon, Aude, Hilgers, Werner, Borchiellini, Delphine, Barthélémy, Philippe, Berger, Raanan, Mermershtain, Wilmosh, Peer, Avivit, Sella, Avishay, Voortman, Johannes, Aarts, Maureen J., Gietema, Jourik A., Choi, Young-Deuk, Gafanov, Rustem A., Kopyltsov, Evgeniy, Carles, Joan, Mellado, Begoña, Maroto, José Pablo, García-Donás, Jesús, Rodríguez Moreno, Juan Francisco, Durán, Ignacio, Pérez-Valderrama, Begoña, Castro, Elena, Olmos, David, Méndez-Vidal, María José, Muñoz-Langa, José, Herranz, Urbano Anido, Puente Vázquez, Javier, Castellanos, Enrique, Hellström, Martin, Widmark, Anders, Lissbrant, Ingela Franck, Jellvert, Åsa, Külich, Cecilia, Blom, René, Kang, Chih-Hsiung, Ou, Yen-Chuan, Wang, Shian-Shiang, Attard, Gerhardt, Bahl, Amit, Kellati, Prasad, Parikh, Omi, Srinivasan, Rajaguru, Lester, Jason F., Staffurth, John N., Cheng, Heather H., Efstathiou, Eleni, Pilié, Patrick G., George, Daniel J., Karsh, Lawrence I., Kelly, W. Kevin, Danila, Daniel C., Smith, Matthew R., Heath, Elisabeth I., Vaishampayan, Ulka N., Emamekhoo, Hamid, Pinski, Jacek K.

    Published in The lancet oncology (01-03-2022)
    “…Metastatic castration-resistant prostate cancers are enriched for DNA repair gene defects (DRDs) that can be susceptible to synthetic lethality through…”
    Get full text
    Journal Article
  15. 15

    Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study by Siefker-Radtke, Arlene O, Necchi, Andrea, Park, Se Hoon, García-Donas, Jesús, Huddart, Robert A, Burgess, Earle F, Fleming, Mark T, Rezazadeh Kalebasty, Arash, Mellado, Begoña, Varlamov, Sergei, Joshi, Monika, Duran, Ignacio, Tagawa, Scott T, Zakharia, Yousef, Akapame, Sydney, Santiago-Walker, Ademi E, Monga, Manish, O'Hagan, Anne, Loriot, Yohann, Necchi, Andrea, Loriot, Yohann, Park, Se Hoon, Tagawa, Scott, Flechon, Aude, Alexeev, Boris, Varlamov, Sergey, Huddart, Robert, Vano, Yann, Gasparro, Donatello, Hamzaj, Alketa, Kopyltsov, Eugeniy, Gracia Donas, Jesus, Mellado, Begona, Parikh, Omi, Schatteman, Peter, Culine, Stephane, Houédé, Nadine, Zanetta, Sylvie, Facchini, Gaetano, Scagliotti, Giorgio, Schinzari, Giovanni, Lee, Jae Lyun, Shkolnik, Mikhail, Fleming, Mark, Joshi, Monica, O'Donnell, Peter, Stöger, Herbert, Decaestecker, Karel, Dirix, Luc, Machiels, Jean Pascal, Borchiellini, Dephine, Delva, Remy, Rolland, Frederic, Hadaschik, Boris, Retz, Margitta, Rosenbaum, Eli, Basso, Umberto, Mosca, Alessandra, Shin, Dong Bok, Cebotaru, Cristina, Duran, Ignacio, Moreno, Victor, Perez Gracia, Jose Luis, Pinto, Alvaro, Su, Wen-Pin, Wang, Shian-Shiang, Schnadig, Ian, Srinivas, Sandhya, Vogelzang, Nicholas, Loidl, Wolfgang, Meran, Johannes, Gross Goupil, Marine, Joly, Florence, Imkamp, Florian, Krege, Susanne, May, Matthias, Schultze-Seemann, Wolfgang, Strauss, Arne, Zimmermann, Uwe, Keizman, Daniel, Peer, Avivit, Sella, Avishai, Berardi, Rossana, De Giorgi, Ugo, Sternberg, Cora Nanette, Rha, Sun Young, Bulat, Iurie, Izmailov, Adel, Matveev, Vsevolod, Vladimirov, Vladimir, Carles, Joan, Font, Albert, Saez, Maribel, Syndikus, Isabel, Tarver, Kathryn, Appleman, Leonard, Burke, John, Dawson, Nancy, Jain, Sharad, Zakharia, Yousef

    Published in The lancet oncology (01-02-2022)
    “…Erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, was shown to be clinically active and tolerable in patients with…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Transperineal vs. transrectal prostate biopsies under local anesthesia: A prospective cohort study on patient tolerability and complication rates by Berquin, Camille, Perletti, Gianpaolo, Develtere, Dries, Van Puyvelde, Hannah, Pauwels, Elisabeth, De Groote, Ruben, D'Hondt, Frederiek, Schatteman, Peter, Mottrie, Alex, De Naeyer, Geert

    Published in Urologic oncology (01-09-2023)
    “…•Transperineal prostate biopsies are the new gold standard in the diagnosis of prostate cancer according to most recent international guidelines.•Transperineal…”
    Get full text
    Journal Article